Vanguard Group
SRTA

Vanguard Group’s Strata Critical Medical Inc SRTA Stock Holding History

Vanguard Group’s Portfolio SRTA Stock Details SRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$17.5M Buy
3,633,537
+253,381
+7% +$1.23M ﹤0.01% 2677
2025
Q3 		$17.1M Buy
3,380,156
+81,141
+2% +$358K ﹤0.01% 2703
2025
Q2 		$13.3M Buy
3,299,015
+44,140
+1% +$144K ﹤0.01% 2753
2025
Q1 		$8.89M Buy
3,254,875
+81,962
+3% +$294K ﹤0.01% 2908
2024
Q4 		$13.5M Buy
3,172,913
+183,941
+6% +$700K ﹤0.01% 2786
2024
Q3 		$8.79M Buy
2,988,972
+60,874
+2% +$194K ﹤0.01% 3022
2024
Q2 		$10.2M Sell
2,928,098
-39,402
-1% -$131K ﹤0.01% 2905
2024
Q1 		$8.46M Buy
2,967,500
+28,622
+1% +$88.3K ﹤0.01% 3053
2023
Q4 		$10.4M Buy
2,938,878
+120,890
+4% +$347K ﹤0.01% 2926
2023
Q3 		$7.3M Buy
2,817,988
+22,090
+0.8% +$77.6K ﹤0.01% 3076
2023
Q2 		$11M Sell
2,795,898
-15,086
-0.5% -$47.9K ﹤0.01% 2891
2023
Q1 		$9.5M Buy
2,810,984
+5,346
+0.2% +$21.8K ﹤0.01% 2959
2022
Q4 		$10M Sell
2,805,638
-2,978
-0.1% -$12.7K ﹤0.01% 2945
2022
Q3 		$11.3M Buy
2,808,616
+50,255
+2% +$258K ﹤0.01% 2898
2022
Q2 		$12.3M Buy
2,758,361
+27,946
+1% +$202K ﹤0.01% 2877
2022
Q1 		$23.2M Buy
2,730,415
+302,362
+12% +$2.12M ﹤0.01% 2684
2021
Q4 		$21.4M Buy
2,428,053
+10,087
+0.4% +$95.9K ﹤0.01% 2808
2021
Q3 		$25.1M Buy
2,417,966
+7,000
+0.3% +$61.1K ﹤0.01% 2724
2021
Q2 		$25.3M Buy
+2,410,966
New +$23.8M ﹤0.01% 2725

Other funds holding SRTA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NRCM
Northern Right Capital Management Darien, Connecticut $281M AUM 56.22% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
PLC
Pillsbury Lake Capital San Francisco, California $221M AUM
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Vanguard Group's SRTA Position: Q4 2025 in Review

Vanguard Group increased its Strata Critical Medical Inc (SRTA) stake by 7.5% in Q4 2025, buying an estimated $1.23M and bringing the position to 3,633,537 shares worth $17.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2677.

Vanguard Group first reported a position in SRTA in Q2 2021 and has held it in 19 quarters since. The position peaked at $25.3M in Q2 2021. 125 funds tracked by Wall St. Rank hold SRTA as of Q4 2025.

  • Vanguard Group held 3,633,537 shares of Strata Critical Medical Inc worth $17.5M as of Q4 2025.
  • Vanguard Group bought 253,381 Strata Critical Medical Inc shares in Q4 2025, an estimated $1.23M.
  • Strata Critical Medical Inc made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #2677 holding.
  • Vanguard Group first reported a position in Strata Critical Medical Inc in Q2 2021 and has held it in 19 quarters since.
  • Vanguard Group's Strata Critical Medical Inc position peaked at $25.3M in Q2 2021.
  • 125 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.